https://doctransparency.com/doctor/fl/jupiter/ashok-muthukrishnan-1588618938
Medicare Enrolled

Dr. Ashok Muthukrishnan, MD

Nuclear Medicine · Jupiter, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
431 UNIVERSITY BLVD, Jupiter, FL 33458
5618473797
In practice since 2006 (19 years)
NPI: 1588618938 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Muthukrishnan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Muthukrishnan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Muthukrishnan

Dr. Ashok Muthukrishnan is a nuclear medicine in Jupiter, FL, with 19 years in practice. Based on federal Medicare data, Dr. Muthukrishnan performed 20,728 Medicare services across 273 unique beneficiaries.

Between the years covered by Open Payments, Dr. Muthukrishnan received a total of $2,589 from 9 pharmaceutical and/or device companies across 29 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nuclear medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Muthukrishnan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 28% volume in FL$ $2,589 industry payments

Medicare Practice Summary

Medicare Utilization ↗
20,728
Medicare services
Top 28% in FL for nuclear medicine
273
Unique beneficiaries
$188
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,091 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie20,400$188$410
Radioactive drug therapy through a vein104$120$265
Nuclear medicine study from skull base to mid-thigh with ct scan47$1,140$4,196
Nuclear medicine study whole body with ct scan34$89$336
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries34$91$660
Ct scan of soft tissue of neck with contrast22$49$208
Ct scan of chest with contrast20$41$250
CT scan of abdomen and pelvis with contrast19$64$378
Nuclear medicine study from skull base to mid-thigh19$68$239
New patient office visit, complex (60-74 min)16$162$370
Nuclear medicine study of bone and/or joint whole body13$31$189
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,589
Total received (2018-2024)
Avg $647/year across 4 years
Top 11% in FL for nuclear medicine
9
Companies
29
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,589 (61.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,000 (38.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,218
2023
$104
2022
$267
2018
$1,000

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Advanced Accelerator Applications
$1,000
Novartis Pharmaceuticals Corporation
$445
United Imaging Healthcare North America LLC
$307
Telix Pharmaceuticals
$292
Siemens Medical Solutions USA, Inc.
$278
PROGENICS PHARMACEUTICALS, INC.
$167
Blue Earth Diagnostics Limited
$46
VOXIMETRY, INC.
$39
GE HealthCare
$15
Top 3 companies account for 67.7% of total payments
Associated products mentioned in payments ›
Axumin · Biograph Vision 600 (8 Ring/64 CT) · ILLUCCIX · LUTATHERA · LUTATHERA (lutetium Lu 177 dotatate) · PLUVICTO · POSLUMA · PYLARIFY · Voximetry Torch · uMI 550 · uMI Panorama
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (61%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $12 per 100 Medicare services performed
Looking for a nuclear medicine in Jupiter?
Compare nuclear medicines in the Jupiter area by procedure volume, costs, and industry payment transparency.
Browse nuclear medicines nearby

Geographic Context

Nuclear Medicines within 10 mi
3
Per 100K population
0.2
County median income
$81,115
Nearest hospital
JUPITER MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Muthukrishnan is a mixed practice specialist, with above-average Medicare volume (top 28% in FL), and high industry engagement (low-engagement, top 11%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Muthukrishnan experienced with lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie?
Based on Medicare claims data, Dr. Muthukrishnan performed 20,400 lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Muthukrishnan receive payments from pharmaceutical companies?
Yes. Dr. Muthukrishnan received a total of $2,589 from 9 companies across 29 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Muthukrishnan's costs compare to other nuclear medicines in Jupiter?
Dr. Muthukrishnan's average Medicare payment per service is $188. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Muthukrishnan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →